FDA gives Snug Seat green light
By HME News Staff
Updated Thu March 19, 2015
MATTHEWS, N.C. - The Food and Drug Administration has released Snug Seat from a product specific hold. The company may now resume distributing 15 products in the United States that are manufactured in Denmark by its parent company R82. Snug Seat has been under a product specific hold for the last 18 months, following the FDA's finding that R82 was in violation of six “good manufacturing requirements.” Snug Seat plans to confirm previously placed orders over the next two weeks and start filling open orders according to inventory and age of order by late March.
Comments